CTAD 2025 Presentation

Hendrix et al

 

Benefit Continues to Accumulate When Treatment is Continued Beyond Plaque Clearance – Estimating Accumulated or Maintained Treatment Benefit in the CLARITY-AD and TRAILBLAZER-ALZ 2 Trials